A digital assay for programmed death-ligand 1 (22C3) quantification combined with immune cell recognition algorithms in non-small cell lung cancer

Will Paces, Roberto Gianani(Flag Therapeutics (United States))

Scientific Reports

June 13, 2022

10.1038/s41598-022-12697-1

Cited by 1

Related Papers

Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 Autoantibodies

|Diabetes|1996|794

HLA-DQB1*0602 Is Associated With Dominant Protection From Diabetes Even Among Islet Cell Antibody–Positive First-Degree Relatives of Patients with IDDM

|Diabetes|1995|196

Prognostically Significant Heterogeneity of Cytoplasmic Islet Cell Antibodies in Relatives of Patients with Type I Diabetes

|Diabetes|1992|107

Late Progression to Diabetes and Evidence for Chronic β-Cell Autoimmunity in Identical Twins of Patients With Type I Diabetes

|Diabetes|1995|103